Weak Patents Are a Weak Deterrent: Patent Portfolios, the Orange Book Listing Standard, and Generic Entry in Pharmaceuticals
Authors: | Hemphill, C. Scott ; Sampat, Bhaven N. |
---|---|
Published in: |
Saved in:
Online Resource
Saved in favorites
Similar items by person
-
Evergreening, patent challenges, and effective market life in pharmaceuticals
Hemphill, C. Scott, (2012)
-
Evergreening, Patent Challenges, and Effective Market Life in Pharmaceuticals
Hemphill, C. Scott, (2013)
-
When Do Generics Challenge Drug Patents?
Hemphill, C. Scott, (2014)
- More ...